CRWVApril 10, 2026 at 11:45 AM UTCSoftware & Services

CoreWeave's Anthropic Deal Reinforces AI Demand Narrative But Leaves Execution Risks Unaddressed

Read source article

What happened

CoreWeave has announced a deal with Anthropic to provide cloud infrastructure for developing and deploying Claude AI models, adding to its portfolio of high-profile AI customers. This agreement supports the company's demand narrative, which already includes major commitments from Microsoft, OpenAI, and Meta, as highlighted in the DeepValue report. However, the report emphasizes that CoreWeave's valuation hinges on executing a $30-35B 2026 capex plan to scale active power to over 1.7GW without delivery delays or margin erosion. Critical risks persist, including third-party data-center delivery delays disclosed in filings and a Q1'26 margin trough with unproven sequential improvement to low-double-digit margins by Q4'26. While the Anthropic deal may incrementally boost backlog, it does not mitigate these core execution and financing challenges that are central to the investment thesis.

Implication

The Anthropic deal underscores CoreWeave's ability to attract top AI clients, potentially adding to its $60.7B RPO and reinforcing long-term demand visibility. However, with existing customer concentration and a massive capex plan, the incremental revenue impact is likely negligible against the backdrop of delivery bottlenecks and margin pressures. Key monitoring points from the DeepValue report—such as active MW adds and adjusted operating margin inflection—are unaffected, meaning the stock's near-term fate still depends on operational proof. Investors must await quarterly results for evidence that CoreWeave can convert backlog into revenue without further delays or equity dilution from financing needs. Maintaining a WAIT rating is prudent until these execution milestones are met, as premature optimism could expose investors to downside from potential guide-downs or capital impairment.

Thesis delta

The investment thesis remains unchanged; the WAIT rating is still justified. This news supports the demand side of the thesis but does not alter the critical dependence on execution—specifically, on-time data-center delivery and margin recovery. Investors should continue to defer entry until observable progress on these fronts is confirmed in upcoming financial reports.

Confidence

Moderate